Clinical trial
Does Reduction of Hyperglycemia With Insulin Impact Restenosis and Improve Clinical Outcomes Following PCI?
NCT00412126 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does Reduction of Hyperglycemia With Insulin Impact Restenosis and Improve Clinical Outcomes Following PCI?
- Lead sponsor
- Hamilton Health Sciences Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2002
- Completion date
- September 30, 2005
- Enrollment
- 240
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.